Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 128, Issue 5, Pages 1067-U526Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2011.06.018
Keywords
Allergic inflammation; asthma; IL-22; eosinophils; IL-25
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology
- Japanese Government
- (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan
- Grants-in-Aid for Scientific Research [21390255, 23790897, 21390147, 23659240, 22021009, 22021011, 23591113, 22689014] Funding Source: KAKEN
Ask authors/readers for more resources
Background: IL-22 functions as both a proinflammatory cytokine and an anti-inflammatory cytokine in various inflammations, depending on the cellular and cytokine milieu. However, the roles of IL-22 in the regulation of allergic airway inflammation are still largely unknown. Objective: We sought to determine whether IL-22 is involved in the regulation of allergic airway inflammation. Methods: We examined IL-22 production and its cellular source at the site of antigen-induced airway inflammation in mice. We also examined the effect of IL-22 neutralization, as well as IL-22 administration, on antigen-induced airway inflammation. We finally examined the effect of IL-22 on IL-25 production from a lung epithelial cell line (MLE-15 cells). Results: Antigen inhalation induced IL-22 production in the airways of sensitized mice. CD4(+) T cells, but not other lymphocytes or innate cells, infiltrating in the airways produced IL-22, and one third of IL-22-producing CD4(+) T cells also produced IL-17A. The neutralization of IL-22 by anti-IL-22 antibody enhanced antigen-induced IL-13 production, eosinophil recruitment, and goblet cell hyperplasia in the airways. On the other hand, intranasal administration of recombinant IL-22 attenuated antigen-induced eosinophil recruitment into the airways. Moreover, anti-IL-22 antibody enhanced antigen-induced IL-25 production in the airways, and anti-IL-25 antibody reversed the enhancing effect of anti-IL-22 antibody on antigen-induced eosinophil recruitment into the airways. Finally, IL22 inhibited IL-13-mediated enhancement of IL-25 expression in IL-1 beta- or LPS-stimulated MLE-15 cells. Conclusion: IL-22 attenuates antigen-induced airway inflammation, possibly by inhibiting IL-25 production by lung epithelial cells. (J Allergy Clin Immunol 2011;128:1067-76.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available